scholarly journals Efektivitas Suplementasi Glukosamin pada Tatalaksana Osteoartritis

2019 ◽  
Vol 8 (2) ◽  
pp. 59-66
Author(s):  
Shinta Melia Desiana ◽  
Jessica Sindy Sirait
Keyword(s):  
Alternative Therapy ◽  
Degenerative Joint Disease ◽  
Google Scholar ◽  
Joint Disease ◽  
Symptomatic Therapy ◽  
Literature Study ◽  
Pharmacological Management ◽  
Low Toxicity ◽  
Inflammatory Drugs ◽  
Anti Inflammatory

Osteoartritis merupakan penyakit sendi degeneratif yang paling umum ditemukan yang mengakibatkan disabilitas, terutama pada lansia. Angka kejadian osteoartritis setiap tahunnya semakin bertambah dikarenakan pertambahan kejadian obesitas serta usia tua sebagai faktor risiko osteoartritis. Penatalaksanaan osteoartritis secara farmakologis hingga saat ini hanya berupa terapi simtomatik yaitu dengan pemberian antinyeri seperti analgesik dan Non-Steroidal Anti-Inflammatory Drugs (NSAID), namun penggunaan obat-obat tersebut dalam jangka panjang akan menimbulkan efek samping, dari yangringan hingga berat. Karena itulah diperlukan terapi alternatif yang efektif untuk tatalaksana osteoartritis. Glukosamin merupakan komponen glikosaminoglikan pada kartilago dan berfungsi untuk mempertahankan fleksibilitas, elastisitas serta pemeliharaan sendi. Hal ini membuat banyak orang yang yakin bahwa glukosamin dapat memberi manfaat sebagai terapi komplementer dalam penatalaksanaan osteoartritis. Metode yang digunakan menggunakan kumpulan sumber pustaka sejumlah 28 artikel dari tahun 2008 hingga 2019, dimana proses pencarian menggunakan Pubmed, Google Scholar, Medline dan Science Direct. Hasil yang didapatkan dari telaah kepustakaan menunjukkan bahwa pemberian suplementasi glukosamin maupun dengan penambahan beberapa senyawa mungkin efektif untuk digunakan dalam penatalaksanaan osteoartritis.   Kata kunci: glukosamin, osteoartritis, tatalaksana   EFFECTIVITY OF GLUCOSAMINE SUPLEMENT IN OSTEOARTHRITIS MANAGEMENT   ABSTRACT Osteoarthritis is the most common degenerative joint disease which can lead to disability, especially in elderly. The number of people affected is increasing every year due to obesity and aging of the population, as the risk factors. To this day, pharmacological management of osteoarthritis has only been symptomatic therapy, including administration of painkillers such as analgesics and Non-Steroidal Anti-Inflammatory Drugs. However, the use of these drugs in long term will cause various adverse effects. Thus, alternative therapy with high efficacy and low toxicity are needed. Glucosamine is a component of glycosaminoglycans in cartilages that serves to maintain strength and elasticity of the joints. This makes many people believe that glucosamine could provide benefits as an additional therapy in managing osteoarthritis. The method uses a collection of research articles as many as 28 articles from 2008 to 2019, where the search process uses the Pubmed, Google Scholar, Medline and Science Direct. The results obtained from the literature study indicate that the administration of glucosamine supplementation and the addition of several compounds might be effective in managing osteoarthritis.   Keywords: glucosamine, osteoarthritis, management

scholarly journals Effects of Glucosamine and Chondroitin Sulfate on Cartilage Metabolism in OA: Outlook on Other Nutrient Partners Especially Omega-3 Fatty Acids

2011 ◽  
Vol 2011 ◽  
pp. 1-17 ◽  
Author(s):  
Jörg Jerosch
Keyword(s):  
Fatty Acids ◽  
Chondroitin Sulfate ◽  
Degenerative Joint Disease ◽  
Joint Disease ◽  
Omega 3 Fatty Acids ◽  
Omega 3 ◽  
Collagen Hydrolysate ◽  
Cartilage Metabolism ◽  
Promising Therapeutic Approach ◽  
Anti Inflammatory

Osteoarthritis (OA) is a degenerative joint disease that is characterized by increasing loss of cartilage, remodeling of the periarticular bone, and inflammation of the synovial membrane. Besides the common OA therapy with nonsteroidal anti-inflammatory drugs (NSAIDs), the treatment with chondroprotectives, such as glucosamine sulfate, chondroitin sulfate, hyaluronic acid, collagen hydrolysate, or nutrients, such as antioxidants and omega-3 fatty acids is a promising therapeutic approach. Numerous clinical studies have demonstrated that the targeted administration of selected micronutrients leads to a more effective reduction of OA symptoms, with less adverse events. Their chondroprotective action can be explained by a dual mechanism: (1) as basic components of cartilage and synovial fluid, they stimulate the anabolic process of the cartilage metabolism; (2) their anti-inflammatory action can delay many inflammation-induced catabolic processes in the cartilage. These two mechanisms are able to slow the progression of cartilage destruction and may help to regenerate the joint structure, leading to reduced pain and increased mobility of the affected joint.

scholarly journals The pathophysiology and medical management of canine osteoarthritis : continuing education

1997 ◽  
Vol 68 (1) ◽  
Author(s):  
T. Vaughan-Scott ◽  
J.H. Taylor
Keyword(s):  
Continuing Education ◽  
Clinical Signs ◽  
Cartilage Degeneration ◽  
Degenerative Joint Disease ◽  
Joint Disease ◽  
Joint Cartilage ◽  
Pharmacological Management ◽  
Gradual Onset ◽  
Joint Surfaces ◽  
Canine Osteoarthritis

Osteoarthritis or degenerative joint disease is a condition characterised by degeneration of articular cartilage often associated with the formation of new bone at joint surfaces or margins. Commonly encountered in dogs, osteoarthritis may have a gradual onset, but may also occur acutely. Osteoarthritis can be a primary disease of joint cartilage, but is more often secondary to abnormal stresses on joints. This article describes the pathogenesis and progression of cartilage degeneration as well as the dietary, lifestyle and pharmacological management of osteoarthritis. Recent pharmacological developments allow the clinician not only to control clinical signs of the disease, but also to slow the progression of cartilage degeneration.

Comparison of piroxicam and naproxen in osteoarthritis of the foot

1994 ◽  
Vol 84 (7) ◽  
pp. 348-354 ◽  
Author(s):  
MB Jennings
Keyword(s):  
Pain Relief ◽  
Joint Disease ◽  
Parallel Study ◽  
Double Blind ◽  
Significant Pain ◽  
The Us ◽  
Inflammatory Drugs ◽  
Anti Inflammatory

Osteoarthritis is the most common joint disease and the second highest ranking cause of disability in the US. Osteoarthritis commonly affects the hands, wrists, spine, knees, and feet. One of the mainstays of treatment for osteoarthritis is the use of nonsteroidal anti-inflammatory drugs. While there have been controlled comparison studies of the various nonsteroidal anti-inflammatory drugs, these have been limited to osteoarthritis of the hands, spine, and hip. This study was a randomized, double-blind, parallel study of 8 weeks' duration comparing piroxicam (Feldene, 20 mg daily) to naproxen (Naprosyn, 1,000 mg daily) in the treatment of osteoarthritis of the foot in 45 patients. Both groups experienced significant pain relief and improvement of mobility.

scholarly journals Mechanisms of Action and Efficacy of Statins against Influenza

2014 ◽  
Vol 2014 ◽  
pp. 1-8 ◽  
Author(s):  
Parvaneh Mehrbod ◽  
Abdul Rahman Omar ◽  
Mohd Hair-Bejo ◽  
Amin Haghani ◽  
Aini Ideris
Keyword(s):  
Influenza Virus ◽  
Alternative Therapy ◽  
Severe Influenza ◽  
Frequent Mutations ◽  
Inflammatory Drugs ◽  
Upper Respiratory ◽  
Anti Inflammatory ◽  
Influenza Outbreaks ◽  
And Control ◽  
Potential Use

The influenza virus (IV) is known to be a resistant virus with frequent mutations, causing severe respiratory diseases in the upper respiratory system. Public health concerns about clinical efficacy of all conventional drugs are ambiguous; therefore, finding additional therapeutic agents is critical to prevent and control influenza outbreaks. Influenza is associated with the induction of proinflammatory cytokines. Scientists have reported that anti-inflammatory drugs, with pleiotropic effects, reduce the burden of severe influenza diseases. Therefore, statins, which are cardioprotective drugs with anti-inflammatory and immunomodulatory effects, may help patients suffering from influenza virus (IV). This review delineates the potential use of statins as an alternative therapy in treating influenza related illness.

scholarly journals Arthritis and the role of endogenous glucocorticoids

Bone Research ◽  
2020 ◽  
Vol 8 (1) ◽  
Author(s):  
Eugenie Macfarlane ◽  
Markus J. Seibel ◽  
Hong Zhou
Keyword(s):  
Rheumatoid Arthritis ◽  
Joint Destruction ◽  
Degenerative Joint Disease ◽  
Joint Disease ◽  
Current Evidence ◽  
Inflammatory Microenvironment ◽  
Glucocorticoid Signaling ◽  
Anti Inflammatory ◽  
Fibroblast Like Synoviocytes

Abstract Rheumatoid arthritis and osteoarthritis, the most common forms of arthritis, are chronic, painful, and disabling conditions. Although both diseases differ in etiology, they manifest in progressive joint destruction characterized by pathological changes in the articular cartilage, bone, and synovium. While the potent anti-inflammatory properties of therapeutic (i.e., exogenous) glucocorticoids have been heavily researched and are widely used in clinical practice, the role of endogenous glucocorticoids in arthritis susceptibility and disease progression remains poorly understood. Current evidence from mouse models suggests that local endogenous glucocorticoid signaling is upregulated by the pro-inflammatory microenvironment in rheumatoid arthritis and by aging-related mechanisms in osteoarthritis. Furthermore, these models indicate that endogenous glucocorticoid signaling in macrophages, mast cells, and chondrocytes has anti-inflammatory effects, while signaling in fibroblast-like synoviocytes, myocytes, osteoblasts, and osteocytes has pro-inflammatory actions in rheumatoid arthritis. Conversely, in osteoarthritis, endogenous glucocorticoid signaling in both osteoblasts and chondrocytes has destructive actions. Together these studies provide insights into the role of endogenous glucocorticoids in the pathogenesis of both inflammatory and degenerative joint disease.

scholarly journals Modulating the Chemical and Biological Properties of Cancer Stem Cell-Potent Copper(II)-Nonsteroidal Anti-Inflammatory Drug Complexes

Molecules ◽  
2019 ◽  
Vol 24 (9) ◽  
pp. 1677 ◽  
Author(s):  
Shin ◽  
Eskandari ◽  
Suntharalingam
Keyword(s):  
Three Dimensional ◽  
Biological Properties ◽  
Culture Studies ◽  
Apoptosis Pathway ◽  
Cytotoxicity Studies ◽  
Ic50 Value ◽  
Low Toxicity ◽  
Inflammatory Drugs ◽  
Anti Inflammatory ◽  
Micromolar Range

Copper(II) complexes bearing nonsteroidal anti-inflammatory drugs (NSAIDs) are known to potently kill cancer stem cells (CSCs), a subpopulation of tumour cells with high metastatic and relapse fidelity. One of the major disadvantages associated to these copper(II) complexes is their instability in the presence of strong cellular reductants (such as ascorbic acid). Here we present a biologically stable copper(II)-NSAID complex containing a bathocuproinedisulfonic acid disodium ligand and two indomethacin moieties, Cu(bathocuproinedisulfonic acid disodium)(indomethacin)2, 2. The copper(II) complex, 2 kills bulk breast cancer cells and breast CSC equally (in the sub-micromolar range) and displays very low toxicity against non-tumorigenic breast and kidney cells (IC50 value > 100 µM). Three-dimensional cell culture studies show that 2 can significantly reduce the number and size of breast CSC mammospheres formed (from single suspensions) to a similar level as salinomycin (an established anti-breast CSC agent). The copper(II) complex, 2 is taken up reasonably by breast CSCs and localises largely in the cytoplasm (>90%). Cytotoxicity studies in the presence of specific inhibitors suggest that 2 induces CSC death via a reactive oxygen species (ROS) and cyclooxygenase isoenzyme-2 (COX-2) dependent apoptosis pathway.

scholarly journals Tabetri™ (Tabebuia avellanedae Ethanol Extract) Ameliorates Osteoarthritis Symptoms Induced by Monoiodoacetate through Its Anti-Inflammatory and Chondroprotective Activities

2017 ◽  
Vol 2017 ◽  
pp. 1-14 ◽  
Author(s):  
Jae Gwang Park ◽  
Young-Su Yi ◽  
Yo Han Hong ◽  
Sulgi Yoo ◽  
Sang Yun Han ◽  
...  
Keyword(s):  
Cell Line ◽  
Proinflammatory Cytokines ◽  
Inflammatory Mediators ◽  
Molecular Mechanisms ◽  
Ethanol Extract ◽  
Degenerative Joint Disease ◽  
Joint Disease ◽  
Cellular Models ◽  
Anti Inflammatory

Although osteoarthritis (OA), a degenerative joint disease characterized by the degradation of joint articular cartilage and subchondral bones, is generally regarded as a degenerative rather than inflammatory disease, recent studies have indicated the involvement of inflammation in OA pathogenesis. Tabebuia avellanedae has long been used to treat various diseases; however, its role in inflammatory response and the underlying molecular mechanisms remain poorly understood. In this study, the pharmacological effects of Tabetri (Tabebuia avellanedae ethanol extract (Ta-EE)) on OA pathogenesis induced by monoiodoacetate (MIA) and the underlying mechanisms were investigated using experiments with a rat model and in vitro cellular models. In the animal model, Ta-EE significantly ameliorated OA symptoms and reduced the serum levels of inflammatory mediators and proinflammatory cytokines without any toxicity. The anti-inflammatory activity of Ta-EE was further confirmed in a macrophage-like cell line (RAW264.7). Ta-EE dramatically suppressed the production and mRNA expressions of inflammatory mediators and proinflammatory cytokines in lipopolysaccharide-stimulated RAW264.7 cells without any cytotoxicity. Finally, the chondroprotective effect of Ta-EE was examined in a chondrosarcoma cell line (SW1353). Ta-EE markedly suppressed the mRNA expression of matrix metalloproteinase genes. The anti-inflammatory and chondroprotective activities of Ta-EE were attributed to the targeting of the nuclear factor-kappa B (NF-κB) and activator protein-1 (AP-1) signaling pathways in macrophages and chondrocytes.

scholarly journals Insights into the Action Mechanisms of Traditional Chinese Medicine in Osteoarthritis

2017 ◽  
Vol 2017 ◽  
pp. 1-13 ◽  
Author(s):  
Linfu Li ◽  
Haiqing Liu ◽  
Weimei Shi ◽  
Hai Liu ◽  
Jianqiong Yang ◽  
...  
Keyword(s):  
Chinese Medicine ◽  
Traditional Chinese Medicine ◽  
Cartilage Destruction ◽  
Degenerative Joint Disease ◽  
Joint Disease ◽  
Action Mechanism ◽  
Action Mechanisms ◽  
Inflammatory Drugs ◽  
Anti Inflammation ◽  
Modern Technologies

Osteoarthritis (OA) is a chronic degenerative joint disease characterized by articular cartilage destruction, synovial inflammation, and osteophyte formation. No effective treatments are available. The current pharmacological medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) and analgesics, accompanied by possible adverse effects, might ameliorate OA symptoms. But they do not arrest the progression of OA. Traditional Chinese medicine (TCM) provides medical value by modification of disease and symptoms in OA. Valuable work on exploring TCM merits for OA patients has been investigated using modern technologies, although the complicated interacting network among the numerous components indicates the uncertainty of target specification. This review will provide an overview of the action mechanism of TCM in the last 5 years, discussing the TCM activities of anti-inflammation, antiapoptosis, antioxidation, anticatabolism, and proliferation in OA. TCM is a proposed medical option for OA treatment.

scholarly journals The Role of Inflammatory and Anti-Inflammatory Cytokines in the Pathogenesis of Osteoarthritis

2014 ◽  
Vol 2014 ◽  
pp. 1-19 ◽  
Author(s):  
Piotr Wojdasiewicz ◽  
Łukasz A. Poniatowski ◽  
Dariusz Szukiewicz
Keyword(s):  
Inflammatory Cytokines ◽  
Intracellular Signaling ◽  
Early Stage ◽  
Degenerative Joint Disease ◽  
Antagonistic Effect ◽  
Joint Disease ◽  
Cytokine Network ◽  
Common Chronic Disease ◽  
Anti Inflammatory

Osteoarthritis (OA) is the most common chronic disease of human joints. The basis of pathologic changes involves all the tissues forming the joint; already, at an early stage, it has the nature of inflammation with varying degrees of severity. An analysis of the complex relationships indicates that the processes taking place inside the joint are not merely a set that (seemingly) only includes catabolic effects. Apart from them, anti-inflammatory anabolic processes also occur continually. These phenomena are driven by various mediators, of which the key role is attributed to the interactions within the cytokine network. The most important group controlling the disease seems to be inflammatory cytokines, including IL-1β, TNFα, IL-6, IL-15, IL-17, and IL-18. The second group with antagonistic effect is formed by cytokines known as anti-inflammatory cytokines such as IL-4, IL-10, and IL-13. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of OA with respect to inter- and intracellular signaling pathways is still under investigation. This paper summarizes the current state of knowledge. The cytokine network in OA is put in the context of cells involved in this degenerative joint disease. The possibilities for further implementation of new therapeutic strategies in OA are also pointed.

scholarly journals Orally Administered NSAIDs—General Characteristics and Usage in the Treatment of Temporomandibular Joint Osteoarthritis—A Narrative Review

2021 ◽  
Vol 14 (3) ◽  
pp. 219
Author(s):  
Marcin Derwich ◽  
Maria Mitus-Kenig ◽  
Elzbieta Pawlowska
Keyword(s):  
Temporomandibular Joint ◽  
Diclofenac Sodium ◽  
Narrative Review ◽  
Joint Disease ◽  
Gastrointestinal Complications ◽  
Pubmed Database ◽  
Increased Risk ◽  
Temporomandibular Joint Osteoarthritis ◽  
Inflammatory Drugs ◽  
Anti Inflammatory

Background: Temporomandibular joint osteoarthritis (TMJ OA) is a degenerative joint disease. The aim of this review was to present the general characteristics of orally administered nonsteroidal anti-inflammatory drugs (NSAIDs) and to present the efficacy of NSAIDs in the treatment of TMJ OA. Methods: PubMed database was analyzed with the keywords: “(temporomandibular joint) AND ((disorders) OR (osteoarthritis) AND (treatment)) AND (nonsteroidal anti-inflammatory drug)”. After screening of 180 results, 6 studies have been included in this narrative review. Results and Conclusions: Nonsteroidal anti-inflammatory drugs are one of the most commonly used drugs for alleviation of pain localized in the orofacial area. The majority of articles predominantly examined and described diclofenac sodium in the treatment of pain in the course of TMJ OA. Because of the limited number of randomized studies evaluating the efficacy of NSAIDs in the treatment of TMJ OA, as well as high heterogeneity of published researches, it seems impossible to draw up unequivocal recommendations for the usage of NSAIDs in the treatment of TMJ OA. However, it is highly recommended to use the lowest effective dose of NSAIDs for the shortest possible time. Moreover, in patients with increased risk of gastrointestinal complications, supplementary gastroprotective agents should be prescribed.

Sign in / Sign up

Export Citation Format

Share Document